PTGX

PROTAGONIST THERAPEUTICS INC

Healthcare | Mid Cap

$0.02

EPS Forecast

$49.84

Revenue Forecast

Announcing earnings for the quarter ending 2024-12-31 soon

Market expectations

EPS Expectation:

$0.02

Revenue Expectation:

$49.84

EPS Surprise Expectation:

$0.015

Revenue Surprise Expectation:

-$2

Post-release price volatility - High

Post-release Overnight Move:

±7.7%

Post-release 1-week Move:

Expected price impact

If company results match EPS & revs consensus exactly:

If company results match Proximilar expectations exactly:

Earnings volatility

EPS standard deviation:

Revenue standard deviation: